share_log

Jefferies Downgrades BELLUS Health to Hold, Lowers Price Target to $14.75

Jefferies Downgrades BELLUS Health to Hold, Lowers Price Target to $14.75

傑富瑞將BELLUS Health的評級下調至持有,將目標股價下調至14.75美元
Benzinga ·  2023/04/19 09:17

Jefferies analyst Suji Jeong downgrades BELLUS Health (NASDAQ:BLU) from Buy to Hold and lowers the price target from $21 to $14.75.

傑富瑞分析師Suji Jeong將BELLUS Health(納斯達克股票代碼:BLU)的評級從買入下調至持有,並將目標股價從21美元下調至14.75美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論